EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Vestibular Schwannoma in the Precision Medicine Era: An Updated Narrative Review of Molecular Insights, Imaging Biomarkers, and Evolving Management Strategies

Flavio Donnini iD, Giovanni Rubino iD, Giuseppe Battaglia iD, Pierpaolo Pastina iD, Marta Vannini iD, Tommaso Carfagno iD, Salvatore Chibbaro iD, Paolo Tini iD

The Journal of International Advanced Otology · 2026

DOI: 10.65717/iao.2026.262358 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of International Advanced Otology, 2026. Verfasst von Flavio Donnini und 7 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Radiation Oncology, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy. Hauptthemen laut MEDLINE: Neuroma, Acoustic, Precision Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vestibular schwannoma (VS) care is increasingly shaped by molecular and imaging advances that complement conventional size- and symptom-based decision-making. Recent multi-omic studies, including single-cell and spatial transcriptomics and methylation profiling, reveal biologically distinct Schwann cell states and microenvironmental programs that may help explain heterogeneous growth, hearing decline, and treatment response. In parallel, quantitative magnetic resonance imaging, radiomics, and early radiogenomic efforts are moving toward standardized, Image Biomarker Standardisation Initiative–compliant pipelines and automated segmentation, enabling more reproducible risk models. Clinically, prospective comparative evidence (e.g., Vestibular schwannoma: Radiosurgery or Expectation and Vestibular Schwannoma International Study of Active Surveillance has refined the observation vs. upfront radiosurgery debate for small-to-medium tumors, while contemporary planning emphasizes cochlear sparing to maximize hearing preservation. Targeted systemic therapy remains mainly relevant for NF2-related disease, with bevacizumab as proof of concept and multiple pathway-directed agents under evaluation. This narrative review synthesizes these developments and outlines a practical framework to integrate biology and imaging biomarkers into individualized surveillance and treatment selection, while highlighting limitations and priorities for multicenter validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroma, AcousticPrecision MedicineHumansMagnetic Resonance ImagingRadiosurgeryBiomarkers, TumorRadiomics

Stichwörter der Autor:innen

Magnetic resonance imagingneurofibromatosis 2precision medicineradiomicsstereotactic radiosurgeryvestibular schwannoma

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Unit of Radiation Oncology, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.
  • Unit of Neurosurgery, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.

ORCID-Profile: Flavio Donnini, Giovanni Rubino, Giuseppe Battaglia, Pierpaolo Pastina, Marta Vannini, Tommaso Carfagno, Salvatore Chibbaro, Paolo Tini

Zitieren

APA

Donnini, F., Rubino, G., Battaglia, G., Pastina, P., Vannini, M., Carfagno, T., Chibbaro, S., & Tini, P. (2026). Vestibular Schwannoma in the Precision Medicine Era: An Updated Narrative Review of Molecular Insights, Imaging Biomarkers, and Evolving Management Strategies. The Journal of International Advanced Otology. https://doi.org/10.65717/iao.2026.262358

Vancouver

Donnini F, Rubino G, Battaglia G, Pastina P, Vannini M, Carfagno T, et al. Vestibular Schwannoma in the Precision Medicine Era: An Updated Narrative Review of Molecular Insights, Imaging Biomarkers, and Evolving Management Strategies. The Journal of International Advanced Otology. 2026. doi:10.65717/iao.2026.262358

BibTeX
@article{Donnini2026,
  author = {Donnini, Flavio and Rubino, Giovanni and Battaglia, Giuseppe and Pastina, Pierpaolo and Vannini, Marta and Carfagno, Tommaso and Chibbaro, Salvatore and Tini, Paolo},
  title = {Vestibular Schwannoma in the Precision Medicine Era: An Updated Narrative Review of Molecular Insights, Imaging Biomarkers, and Evolving Management Strategies},
  journal = {The Journal of International Advanced Otology},
  year = {2026},
  doi = {10.65717/iao.2026.262358}
}
Kostenlos starten →